Tsao A - Search Results

1

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.

Chang JY, Lin SH, Dong W, Liao Z, Gandhi SJ, Gay CM, Zhang J, Chun SG, Elamin YY, Fossella FV, Blumenschein G, Cascone T, Le X, Pozadzides JV, Tsao A, Verma V, Welsh JW, Chen AB, Altan M, Mehran RJ, Vaporciyan AA, Swisher SG, Balter PA, Fujimoto J, Wistuba II, Feng L, Lee JJ, Heymach JV. Chang JY, et al. Among authors: tsao a. Lancet. 2023 Sep 9;402(10405):871-881. doi: 10.1016/S0140-6736(23)01384-3. Epub 2023 Jul 18. Lancet. 2023. PMID: 37478883 Clinical Trial.

2

Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Rice DC, et al. Among authors: tsao as. Ann Thorac Surg. 2005 Dec;80(6):1988-92; discussion 1992-3. doi: 10.1016/j.athoracsur.2005.06.014. Ann Thorac Surg. 2005. PMID: 16305830

3

Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Tsao AS, et al. Cancer. 2006 Jun 1;106(11):2428-36. doi: 10.1002/cncr.21884. Cancer. 2006. PMID: 16634096 Free article.

4

Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.

Thomas SK, Fossella FV, Liu D, Schaerer R, Tsao AS, Kies MS, Pisters KM, Blumenschein GR Jr, Glisson BS, Lee JJ, Herbst RS, Zinner RG. Thomas SK, et al. Clin Lung Cancer. 2006 Mar;7(5):326-31. doi: 10.3816/CLC.2006.n.014. Clin Lung Cancer. 2006. PMID: 16640804

5

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. Tsao AS, et al. J Clin Oncol. 2006 Sep 1;24(25):4163-9. doi: 10.1200/JCO.2006.05.7851. J Clin Oncol. 2006. PMID: 16943532 Clinical Trial.

6

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

Tsao AS, Tang XM, Sabloff B, Xiao L, Shigematsu H, Roth J, Spitz M, Hong WK, Gazdar A, Wistuba I. Tsao AS, et al. J Thorac Oncol. 2006 Mar;1(3):231-9. doi: 10.1016/s1556-0864(15)31573-2. J Thorac Oncol. 2006. PMID: 17409862 Free article.

7

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Tsao AS, He D, Saigal B, Liu S, Lee JJ, Bakkannagari S, Ordonez NG, Hong WK, Wistuba I, Johnson FM. Tsao AS, et al. Mol Cancer Ther. 2007 Jul;6(7):1962-72. doi: 10.1158/1535-7163.MCT-07-0052. Mol Cancer Ther. 2007. PMID: 17620427

8

Malignant pleural mesothelioma.

Tsao AS, Wistuba I, Roth JA, Kindler HL. Tsao AS, et al. J Clin Oncol. 2009 Apr 20;27(12):2081-90. doi: 10.1200/JCO.2008.19.8523. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255316 Free PMC article. Review.

9

Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.

Tsao AS, Mehran R, Roth JA. Tsao AS, et al. Clin Lung Cancer. 2009 Jan;10(1):36-41. doi: 10.3816/CLC.2009.n.005. Clin Lung Cancer. 2009. PMID: 19289370 Review.

10

Radiotherapy in malignant pleural mesothelioma.

McAleer MF, Tsao AS, Liao Z. McAleer MF, et al. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):326-37. doi: 10.1016/j.ijrobp.2009.06.037. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735859 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page